Skip to content

About RaphAI

Company background

Headquartered in Hong Kong, China, with its second base in Guangzhou, RaphAI Health Technologies Limited is strategically positioned to transform the HKSAR and Great Bay Area public and private MSK care sectors into the world’s most AI-adopted market. We aim to serve as the regional hub for ASEAN expansion through deep collaboration with local Third-Party-Administrator (TPA) networks.
Meet our founders

Image source: http://www.hkstp.org

We are proud to become a member of the Hong Kong Science and Technology Park (HKSTP) in 2023 and to spearhead AI-based health tech development alongside other top health tech talent in Hong Kong SAR.

Know more about HKSTP

Our belief

More sustainable, affordable and accessible

We believe Asian MSK markets need an innovative disruption. The current MSK caregiver vs. total population ratio in China and ASEAN markets is more than 10 times lower than those in the US & EU markets.  With the ageing population trend, most Asian markets, including China are facing a steep challenge in improving the existing MSK care system efficiency.  In ASEAN markets, there is a fast growing organic demand for more advanced MSK care services with a rising population and GDP per capita.  

We believe the existing physical clinic visit-only patient journey and model is not a long-term sustainable way to meet the sharp growing demand.

We believe Asian people deserve more affordable, easily accessible professional MSK care to help with their pain management.

We believe our technology can disrupt and help more Asians be relieved from pain.

Explore our FlexMSK solutions

For Clinics / NGO

Scale your MSK care and accelerate patients’ recovery at a lower cost.

For clinics / NGO

For Schools

Simplify students’ health programmes with less admin work.

For schools